Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Macrogenics (MGNX)

Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205,863
  • Shares Outstanding, K 62,763
  • Annual Sales, $ 58,750 K
  • Annual Income, $ -9,060 K
  • EBIT $ -107 M
  • EBITDA $ -102 M
  • 60-Month Beta 2.08
  • Price/Sales 3.72
  • Price/Cash Flow N/A
  • Price/Book 1.82

Options Overview Details

View History
  • Implied Volatility 62.96% ( -13.43%)
  • Historical Volatility 81.34%
  • IV Percentile 7%
  • IV Rank 9.70%
  • IV High 283.51% on 05/09/24
  • IV Low 39.26% on 10/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 207
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 6,924
  • Open Int (30-Day) 8,105

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.23
  • Number of Estimates 4
  • High Estimate -0.07
  • Low Estimate -0.42
  • Prior Year -0.75
  • Growth Rate Est. (year over year) +69.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.16 +1.27%
on 11/21/24
5.10 -37.25%
on 11/06/24
-0.66 (-17.10%)
since 10/21/24
3-Month
2.95 +8.43%
on 09/24/24
5.10 -37.25%
on 11/06/24
-0.40 (-11.11%)
since 08/21/24
52-Week
2.95 +8.43%
on 09/24/24
21.88 -85.37%
on 03/06/24
-4.21 (-56.82%)
since 11/21/23

Most Recent Stories

More News
MacroGenics to Participate in Upcoming Investor Conferences

MGNX : 3.22 (-1.83%)
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript

MGNX earnings call for the period ending September 30, 2024.

MGNX : 3.22 (-1.83%)
MacroGenics: Q3 Earnings Snapshot

MacroGenics: Q3 Earnings Snapshot

MGNX : 3.22 (-1.83%)
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

MGNX : 3.22 (-1.83%)
MacroGenics Announces Leadership Transition

MGNX : 3.22 (-1.83%)
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

MGNX : 3.22 (-1.83%)
Do Options Traders Know Something About MacroGenics (MGNX) Stock We Don't?

Investors in MacroGenics, Inc. MGNX need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $35.00 Call had some of the highest implied volatility...

MGNX : 3.22 (-1.83%)
MacroGenics: Q2 Earnings Snapshot

MacroGenics: Q2 Earnings Snapshot

MGNX : 3.22 (-1.83%)
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 0.9801 (-1.84%)
ONC.TO : 1.38 (-1.43%)
RHHBY : 35.3800 (+0.71%)
MRUS : 45.06 (+4.96%)
MGNX : 3.22 (-1.83%)
IMRX : 2.16 (+5.89%)
Stock Index Futures Climb as Fed Rate Cut Hopes Grow, Fed Speak and ECB Minutes in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.40%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.44% this morning after three major U.S. benchmark indices ended the regular session in the green...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
EQIX : 925.06 (+0.67%)
APP : 321.11 (-1.26%)
AFRM : 66.05 (+4.53%)
EPAM : 245.47 (+4.68%)
ABNB : 133.94 (-0.97%)
IVG.M.DX : 9.144 (+0.62%)
ZAL.D.DX : 27.680 (+1.10%)
NVAX : 8.15 (+1.12%)
ARRY : 6.41 (+0.63%)
VSCO : 35.27 (-2.16%)

Business Summary

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics...

See More

Key Turning Points

3rd Resistance Point 3.73
2nd Resistance Point 3.61
1st Resistance Point 3.45
Last Price 3.22
1st Support Level 3.17
2nd Support Level 3.05
3rd Support Level 2.89

See More

52-Week High 21.88
Fibonacci 61.8% 14.65
Fibonacci 50% 12.42
Fibonacci 38.2% 10.18
Last Price 3.22
52-Week Low 2.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar